In a recent independent survey, 100% of respondents said HFS’ depth of industry knowledge represented ‘Best in Class’ research insight for clients.
100% of respondents also said we rated ‘Good to Excellent’ for product innovation, providing market-leading inspirational research.
Our research is based on over 5000 enterprise interviews conducted annually across the Global2000 and read by millions of business people worldwide. We help you have an impact.
The TMT industry is a springboard for horizontal cross-industry solutions.Published: April 23, 2021
In January 2021, Sanofi, Capgemini, Generali, and Orange joined hands to build a joint venture for developing patient-centric healthcare solutions that can be used across Europe. The new entity will be launched virtually in October 2021 and physically in December 2021.Published: April 23, 2021
Genpact UK chosen as the partner to supply the AI for the crucial role of rapidly evaluating all adverse drug reactions.Published: April 23, 2021
The TMT market is expanding, converging, and becoming hyper-specialized.Published: April 22, 2021
The HFS take on sustaining Mphasis’ success with its growth CEO, Nitin RakeshPublished: April 20, 2021